Chiron Vaccines Get Shot In The Arm With PowderJect Needleless Technology
Executive Summary
Chiron will gain access to PowderJect's needleless vaccine technology and a platform through which to launch vaccines in the U.S. with its $878 mil. acquisition of the Fluvirin manufacturer
You may also be interested in...
MedImmune Aims To Double Pharmacies Offering FluMist; WalMart Passes
MedImmune's FluMist will be available in several chain drug stores in 2003, including Safeway, Kroger's and Albertson's, even though WalMart has reversed course on offering the intranasal flu vaccine
MedImmune Aims To Double Pharmacies Offering FluMist; WalMart Passes
MedImmune's FluMist will be available in several chain drug stores in 2003, including Safeway, Kroger's and Albertson's, even though WalMart has reversed course on offering the intranasal flu vaccine
Chiron pharma research
Pharmacia VP-Discovery Oncology Kenneth Bair, MD, joins Chiron as senior VP-BioPharma research head, effective July 1. He will oversee chemistry, biology, applied biochemistry and discovery projects, and "work with the research head of Chiron's Vaccines and Blood Testing business units to promote organizational synergies," Chiron says. Chiron acquired the vaccine manufacturer Powderject in May (1"The Pink Sheet" May 26, 2003, p. 17). Invenux CEO Carl Pelzel joins Chiron as VP-BioPharma commercial operations...